https://www.selleckchem.com/pr....oducts/empagliflozin
https://www.selleckchem.com/pr....oducts/empagliflozin
Generator cortex modulation and also reward in children with attention-deficit/hyperactivity condition. The primary hypothesis for both XIENCE 90 and XIENCE 28 is that a short DAPT regimen will be non-inferior to a conventional DAPT duration with respect to the composite of all-cause death or MI. Patients enrolled in the prospective multicenter post-market XIENCE V USA study will be used as historical control group in a stratified propensity-adjusted ana